Analysts think DARE stock price could increase by 839%
Jun 14, 2024, 6:29 AM
-0.64%
What does DARE do
Daré Bioscience, Inc., based in San Diego, specializes in developing and marketing pharmaceuticals aimed at women's reproductive health, including products like XACIATO for bacterial vaginosis and a portfolio of clinical and pre-clinical programs such as Ovaprene and Sildenafil Cream 3.6%. The company, which went public in 2014, employs 25 people and focuses on contraception, vaginal health, menopause, sexual health, and fertility.
6 analysts think DARE stock price will increase by 838.58%. The current median analyst target is $4.08 compared to a current stock price of $0.43. The lowest analysts target is $2.02 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
